UnicoCell Biomed Co., Ltd.

NT$64.50As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6794Healthcare
Country Taiwan
PE (Fwd) •••
TSR 6Y CAGR 7.32%
Div yield —
ROE (13.14%)
Biotechnology
Beta (5Y) (0.19)
PE TTM —
TSR TTM (6.11%)
Mkt cap NT$4.105B
ROIC (9.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$77
19.56%
(66.37%)
Buy 12|1|7|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.93
1.00
1.02
1.03
(0.35%)
9.69%
17.42%
21.18%
RevenueNT$M
225.6
219.7
227.2
238.6
5.07%
(1.99%)
4.02%
8.25%
Peers (US$124.0M)
Cap (US$)
PE
133.6M
—
116.7M
—
124.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.421
(0.112)
(0.100)
EBIT/Intx
1.357
0.118
0.127
Own earn%
(25.70)
15.64
15.23
Sh yield%
14.93
38.70
33.37
Owners
Insiders/Inst%
14.85
65.60
Short interest%
2.81
SBC / revenue%
0.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
2–10
$1 testx
—
Incr. ROIC%
5